"Pharmaceutical headlines" fake milk powder past, Yin and Yang company, big head dolls and joint letter

(2020/05/15) over-purchase 1000 times medical device "star shares" PeiJia Medical listed today; Hansen class 2 biological new drug HS-20090 injection approved clinical; 1 year total survival rate increased to 67.2% advanced liver cancer immunotherapy clinical trial results significantlyAt present, the medical community is responding to the COVID-19 pandemic at an alarming rate, and there have been many good examples in drug and vaccine developmentHowever, if you look back at the more than 1,000 COVID-19 intervention clinical trials that are currently under way, we'll find that the field is in disarrayThe pace and mass of the COVID-19 study make the cracks in the system more obvioustoday, the interventional medical device company Peijia Medical (09996-HK) was listed in Hong KongToday's opening price was 26.8 yuan, up more than 70%On May 5, MrPei offered to sell 152,511 million shares at HK$15.36 per shareAfter the opening of the offering, the market was in full swing, with 10 per cent of the public offerings being oversubscribed by 1183.4 times and the proportion of the callback mechanism activated increasing to 50 per centOn May 14th, Peijia Medical opened 63% to 25 yuanIndustry sources pointed out that PeiJia Medical is expected to be this year's "frozen king."'s performance at Peijia Medical is worth looking forward toMay 13, the Guangdong Provincial Drug Trading Center issued the "Guangdong Province Drug Trading Center Retail Drug Trading Implementation Measures", the retail drug transactions in retail drug transactions have made clear the procurement subject, bargaining methods, distribution and settlement, and will be formally implemented on April 30, 2020Guangdong has the largest number of pharmacies, with 54,000 in 2018Make it clear that retail pharmacies, pharmaceutical e-commerce companies, non-public medical institutions and procurement complexes have procurement needs that can be registered on the retail platform at any timeThe procurement method includes the entrustment bargain and the independent bargaining, and the transaction price is not disclosed to the publicThe purchaser pays all drug transactions through the retail platform within 30 days of the delivery (production) enterprise uploading the invoice "
the effectiveness of the health insurance band procurement experience in the form of retail pharmacies welcome to introduce thousands of households May 13, the Xinjiang Autonomous Region Medical Insurance Bureau "on the implementation of the autonomous region drug centralized procurement and use of pilot expansion of the work of medical insurance support measures" (hereinafter referred to as "Notice"), to unify the region's overall funding to pay all levels of fixed-point pharmaceutical institutions at all levels of the same drug payment standards unsurprisingly will become a unified national price limit standard July, Mr Zhu from Wuhan, Hubei Province, wrote in a letter to the People's Daily: Because of the lack of breast milk, my baby from half a year old began to eat milk powder, but slowly found that the baby is allergic to ordinary milk powder, so according to the doctor "to eat formula for the baby" advice, I purchased "Yaledi" moderate hydrolysium formula in December last year After a few listens, the baby's allergic reaction did not improve, and the product appeared clotting phenomenon there is nothing new in the sun affected by the COVID-19 outbreak, ACSO will also hold an online conference this year ASCO is the world's largest annual conference on cancer clinical research, publishing clinical data on new mechanism drugs, mature-based drugs, and clinical testing or markers In recent years, domestic enterprises are increasingly participating in international conferences, increasing the global voice in the field of new drug research China's innovative medicine is a great god days ago, Hansen Pharmaceuticals announced that the new class 2 biological drug HS-20090 injection, developed by its subsidiary Hansen Bio and Howson Pharmaceuticals, has been approved for clinical trial In recent years, Howson pharmaceutical research and development efforts have been strengthened year by year, innovation inflection point has come Howson Pharmaceuticals has more concentrated revenue from listed generic strains
The latest issue of the new issue of the New England Journal of Medicine, the New England Journal, publishes the full data for IMbrave150, a clinical trial of Phase III clinical trial of advanced liver cancer in the artire-pearl-resistant combined beva-zumas The results showed that in patients with non-reprecision liver cancer, compared with Sorafini, attalizoli anti-joint bevazumab treatment led to better total survival and no progression of survival outcomes, and the total survival rate of 12 months increased from 54.6% (95% CI, 45.2 to 64.0) to 67.2% (95% CI, 61.3 to 73.1) offers new hope for the treatment of advanced liver cancer.